These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 2455133

  • 21. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K, Nakai T, Tamai T, Kutsumi Y, Kobayashi T, Hayashi T, Yamada S, Takeda R.
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [Abstract] [Full Text] [Related]

  • 22. Beta-blockers, plasma lipids, and coronary heart disease.
    Cruickshank JM.
    Circulation; 1990 Sep; 82(3 Suppl):II60-5. PubMed ID: 1975524
    [Abstract] [Full Text] [Related]

  • 23. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat.
    Venkatesan N, Devaraj SN, Devaraj H.
    Eur J Nutr; 2003 Oct; 42(5):262-71. PubMed ID: 14569407
    [Abstract] [Full Text] [Related]

  • 24. The association between antihypertensive drug therapies and plasma lipid levels in the general population.
    Maitland-van der Zee AH, Klungel OH, Kloosterman JM, Seidell JC, Leufkens HG, de Boer A.
    J Hum Hypertens; 2001 Oct; 15(10):701-5. PubMed ID: 11607800
    [Abstract] [Full Text] [Related]

  • 25. [Effect of anti-hypertensive treatment on plasma lipids and lipoproteins (author's transl)].
    Sauvanet JP, Rouffy J.
    Pathol Biol (Paris); 1981 Sep; 29(7):435-40. PubMed ID: 6117048
    [Abstract] [Full Text] [Related]

  • 26. [Effect of anti-hypertensive treatment on plasma lipids and lipoproteins (author's transl)].
    Sauvanet JP, Rouffy J.
    Sem Hop; 1982 Mar 04; 58(9):563-8. PubMed ID: 6121378
    [Abstract] [Full Text] [Related]

  • 27. Mechanisms of action of adrenergic receptor blockers on lipids during antihypertensive drug treatment.
    Rabkin SW.
    J Clin Pharmacol; 1993 Mar 04; 33(3):286-91. PubMed ID: 8096525
    [Abstract] [Full Text] [Related]

  • 28. [Effect of three antihypertensive drug groups on lipid metabolism. Effects of alpha receptor blockers, central sympatholytic drugs and vasodilators].
    Jacob BG, Richter WO, Schwandt P.
    Fortschr Med; 1993 Mar 20; 111(8):126-9. PubMed ID: 8099558
    [Abstract] [Full Text] [Related]

  • 29. The effects of diuretics and adrenergic-blocking agents on plasma lipids.
    Rohlfing JJ, Brunzell JD.
    West J Med; 1986 Aug 20; 145(2):210-8. PubMed ID: 2876554
    [Abstract] [Full Text] [Related]

  • 30. Do beta-blockers alter lipids and what are the consequences?
    Holtzman E, Rosenthal T, Goldbourt U, Segal P.
    J Cardiovasc Pharmacol; 1987 Aug 20; 10 Suppl 2():S86-92; discussion S93. PubMed ID: 2481177
    [Abstract] [Full Text] [Related]

  • 31. [Recent trend in the research of hypertension in Japan. The effects of antihypertensive drugs on serum lipids and lipoproteins in patients with mild to moderate hypertension].
    Goto Y, Tamachi H.
    Nihon Naika Gakkai Zasshi; 1988 Dec 20; 77(12):1820-5. PubMed ID: 2907996
    [No Abstract] [Full Text] [Related]

  • 32. Comparison of effects on lipid metabolism of antihypertensive drugs with alpha- and beta-adrenergic antagonist properties.
    Leren P.
    Am J Med; 1987 Jan 05; 82(1A):31-5. PubMed ID: 2879461
    [Abstract] [Full Text] [Related]

  • 33. Blood lipids and antihypertensive drugs. The Oslo study.
    Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG.
    J Pharmacol; 1983 Jan 05; 14 Suppl 2():217-20. PubMed ID: 6632918
    [Abstract] [Full Text] [Related]

  • 34. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar 05; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 35. Long-term effects of antihypertensives on blood lipids.
    Ballantyne D.
    J Hum Hypertens; 1990 Jun 05; 4 Suppl 2():35-7. PubMed ID: 1973462
    [Abstract] [Full Text] [Related]

  • 36. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M, Richter WO, Schwandt P, Holzgreve H.
    Int J Clin Pharmacol Ther; 1997 Jun 05; 35(6):231-4. PubMed ID: 9208337
    [Abstract] [Full Text] [Related]

  • 37. Effects of adrenergic antihypertensive drugs on sterol synthesis in freshly isolated human mononuclear leukocytes.
    Krone W, Müller-Wieland D, Greten H.
    J Cardiovasc Pharmacol; 1985 Jun 05; 7(6):1134-7. PubMed ID: 2418300
    [Abstract] [Full Text] [Related]

  • 38. Possible biochemical mechanisms involved in the antihypertensive drug-induced changes in serum lipoproteins.
    Lijnen P, Fagard R, Staessen J, Amery A.
    Methods Find Exp Clin Pharmacol; 1989 Jan 05; 11(1):17-23. PubMed ID: 2654525
    [Abstract] [Full Text] [Related]

  • 39. Effects of doxazosin and propranolol administration on lipoprotein lipases in cholesterol-fed rats.
    Jansen H, Baggen RG.
    J Cardiovasc Pharmacol; 1987 Jan 05; 10 Suppl 9():S16-20. PubMed ID: 2447435
    [Abstract] [Full Text] [Related]

  • 40. Effects of alpha 1-inhibition on lipid metabolism in the rat.
    Woodside WF, Swindell AC.
    J Cardiovasc Pharmacol; 1987 Jan 05; 10 Suppl 9():S27-34. PubMed ID: 2447438
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.